Therapeutic effect of vitamin D on Hashimoto thyroiditis

Phase 2

Recruiting

• Conditions: Hashimoto thyroiditis.; Disorders of other endocrine glands; E20-E35

• Registration Number: IRCT20180228038900N1
• Lead Sponsor: Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 May 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

All patients under the age of 18 with diagnosis of Hashimoto thyroiditis based on laboratory findings and ultrasonography.

Exclusion Criteria

Exit criteria: Patients with thyroid disease, with or without goiter, with normal levels of antibodies, are excluded.Patients with Hashimoto thyroiditis who were already treated.Patients with thyroid disease with or without goiter have normal levels of autoantibodies.Patients with certain chromosomal syndromes, including Down or Turner.Patients with liver and kidney disease.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome : The therapeutic effects of vitamin D on the level of thyroid autoantibodies in Hashimoto thyroiditis. Timepoint: Time zero and six months later. Method of measurement: blood test.

Secondary Outcome Measures

Name	Time	Method
Secondary outcomes: The therapeutic effects of vitamin D on reducing thyroid gland in Hashimoto thyroiditis. Timepoint: Time zero and six months later. Method of measurement: sonography.